Metsera (MTSR) 8-K Summary: Litigation & Bidding War

• Event Date: November 3, 2025.
• Material Event: Metsera issued a statement responding to litigation filed by Pfizer Inc. concerning Pfizer’s proposed acquisition.

Metsera asserts Pfizer is litigating “to buy Metsera for a lower price than Novo Nordisk.”

• Strategic Conflict: The filing confirms an active bidding scenario involving Pfizer and a competing unsolicited proposal from Novo Nordisk A/S.
• Key Risks Highlighted:
  • Defending against Pfizer litigation (costs/damages).
  • Impact o